Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes
- PMID: 28546444
- DOI: 10.1096/fj.201700110R
Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes
Abstract
Glial fibrillary acidic protein (GFAP) is expressed in peri-islet Schwann cells, as well as in glia cells, and has been reported to be an autoantigen candidate for type 1 diabetes mellitus (T1DM). We confirmed that the production of the autoantibodies GFAP and glutamic acid decarboxylase 65 (GAD65) was increased and inversely correlated with the concentration of secreted C peptide in female nonobese diabetic mice (T1DM model). Importantly, the development of T1DM in female nonobese diabetic mice at 30 wk of age was predicted by the positive GFAP autoantibody titer at 17 wk. The production of GFAP and GAD65 autoantibodies was also increased in KK-Ay mice [type 2 diabetes mellitus (T2DM) model]. In patients with diabetes mellitus, GFAP autoantibody levels were increased in patients with either T1DM or T2DM, and were significantly associated with GAD65 autoantibodies but not zinc transporter 8 autoantibodies. Furthermore, we identified a B-cell epitope of GFAP corresponding to the GFAP autoantibody in both mice and patients with diabetes. Thus, these results indicate that autoantibodies against GFAP could serve as a predictive marker for the development of overt autoimmune diabetes.-Pang, Z., Kushiyama, A., Sun, J., Kikuchi, T., Yamazaki, H., Iwamoto, Y., Koriyama, H., Yoshida, S., Shimamura, M., Higuchi, M., Kawano, T., Takami, Y., Rakugi, H., Morishita, R., Nakagumi, H. Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes.
Keywords: GAD65; autoantibody; nonobese diabetic; type 1 diabetes; type 2 diabetes.
© FASEB.
Similar articles
-
Evaluating the potential of the GFAP-KLH immune-tolerizing vaccine for type 1 diabetes in mice.FEBS Lett. 2017 Jan;591(1):129-136. doi: 10.1002/1873-3468.12511. Epub 2016 Dec 20. FEBS Lett. 2017. PMID: 27926781
-
Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive.Nat Med. 2003 Feb;9(2):198-205. doi: 10.1038/nm818. Epub 2003 Jan 21. Nat Med. 2003. PMID: 12539039
-
Targeting of pancreatic glia in type 1 diabetes.Diabetes. 2008 Apr;57(4):918-28. doi: 10.2337/db07-0226. Epub 2008 Jan 15. Diabetes. 2008. PMID: 18198358
-
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature.Front Immunol. 2018 Dec 5;9:2802. doi: 10.3389/fimmu.2018.02802. eCollection 2018. Front Immunol. 2018. PMID: 30568655 Free PMC article. Review.
-
Prediction and prevention of Type 1 diabetes mellitus.J Diabetes. 2011 Mar;3(1):48-57. doi: 10.1111/j.1753-0407.2010.00102.x. J Diabetes. 2011. PMID: 21073664 Review.
Cited by
-
APOE ε4 carrier status modifies plasma p-tau181 concentrations in cognitively healthy super-seniors.Alzheimers Dement. 2024 Jun;20(6):4373-4380. doi: 10.1002/alz.13804. Epub 2024 May 16. Alzheimers Dement. 2024. PMID: 38752508 Free PMC article.
-
Immune System Sex Differences May Bridge the Gap Between Sex and Gender in Fibromyalgia.Front Neurosci. 2020 Jan 17;13:1414. doi: 10.3389/fnins.2019.01414. eCollection 2019. Front Neurosci. 2020. PMID: 32009888 Free PMC article.
-
Multi-Omics Comparison of the Spontaneous Diabetes Mellitus and Diet-Induced Prediabetic Macaque Models.Front Pharmacol. 2021 Nov 22;12:784231. doi: 10.3389/fphar.2021.784231. eCollection 2021. Front Pharmacol. 2021. PMID: 34880765 Free PMC article.
-
GFAP at 50.ASN Neuro. 2020 Jan-Dec;12:1759091420949680. doi: 10.1177/1759091420949680. ASN Neuro. 2020. PMID: 32811163 Free PMC article. Review.
-
The Role of Accessory Cells in Islet Homeostasis.Curr Diab Rep. 2018 Sep 28;18(11):117. doi: 10.1007/s11892-018-1096-z. Curr Diab Rep. 2018. PMID: 30267158 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous